Drug intelligence / Profile preview

xitix

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Oral, Intramuscular, Intravenous, Intravaginal
01

Overview

**Xitix** is a brand name for a vitamin C (ascorbic acid) preparation developed by Woelm Pharma, primarily used for the prevention and treatment of hypo- and avitaminosis C. Ascorbic acid is essential for intracellular collagen formation, strengthening teeth, bones, and capillary walls, while participating in redox reactions, tyrosine metabolism, folic acid conversion, carbohydrate/lipid/protein synthesis, iron metabolism, and cellular respiration; it enhances infection resistance, iron absorption, and acts as an antioxidant. For systemic use, it addresses increased vitamin C needs during growth, pregnancy, lactation, heavy loads, fatigue, recovery from illness, and winter infection risk; intravaginally, it normalizes vaginal pH and microflora in chronic/recurrent vaginitis. Administered orally, IM, IV, or intravaginally, with dosages of 25-75 mg/day for prevention and 250 mg/day or more for treatment.[1]

Brand names
Xitix
Other names
Kalk-xitix

Beyond the preview

Go deeper on xitix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on xitix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call